Search for: "Oxley, in Re"
Results 461 - 475
of 475
Sorted by Relevance
|
Sort by Date
7 Jun 2011, 6:12 am
After a lengthy hiatus, we’re back on track with our Shingular Sensations, where we focus on solos who have achieved important victories or are otherwise doing interesting work. [read post]
28 Mar 2010, 9:40 pm
When you read this stuff you're saying five years from now, you're going to cringe in embarrassment like the rest of us are doing as we speak. [read post]
13 Jan 2016, 5:05 pm
John Reed Stark David Fontaine In this day and age, the members of the boards of directors of most companies understand that cybersecurity issues are both important and should be a board-level priority. [read post]
4 Dec 2009, 6:31 am
Many directors and other corporate stakeholders are hopeful that if boards are successful in improving their own practices, they may be able to avoid another substantial re-regulation of public companies, in the style of the Sarbanes-Oxley Act of 2002. [read post]
16 Apr 2020, 4:55 am
April 16, 2020 Clients, Friends, Associates: The first quarter of 2020 saw an unprecedented combination of challenges, not only industry-wide but on a global scale as well. [read post]
5 Apr 2012, 6:26 pm
Compliance with the auditor attestation requirement of Section 404(b) of the Sarbanes-Oxley Act is not required for the period that a company remains an EGC. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007:… [read post]
24 Jun 2024, 9:01 pm
The Sarbanes-Oxley Act mandates that we review each reporting company at least once every three years; however, we review a significant number of companies more frequently. [read post]
7 May 2010, 10:00 pm
Below, we discuss the most significant aspects of Elena Kagan’s experience and writings as they relate to the Supreme Court. [read post]
2 Feb 2010, 11:25 am
Because they're so useful! [read post]
2 Feb 2010, 11:25 am
Because they're so useful! [read post]
4 Mar 2010, 6:09 am
Every decade, it seems, government predictably considers and often passes legislation: in the late seventies, the Foreign Corrupt Practices Act; in the eighties, the Corporate Democracy Act (which, in fact, did not pass); in the early years of this century, Sarbanes Oxley; and most recently, Barney Frank and Chris Dodd’s almost Quixotic struggle to produce a pre-election reform bill. [read post]
6 Sep 2012, 1:53 am
Every fall since I first started writing this blog, I have assembled a list of the current hot topics in the world of directors’ and officers’ liability. [read post]
23 Feb 2010, 6:16 am
Editor’s Note: John Olson is a founding partner of Gibson, Dunn & Crutcher’s Washington, D.C. office and a visiting professor at the Georgetown Law Center. [read post]
2 Jan 2018, 5:08 pm
The Trump Administration Re-Shapes the Federal Judiciary President Trump’s appointment of Neil Gorsuch to the U.S. [read post]
